Regencell Bioscience Holdings Limited

NASDAQ:RGC

14.86 (USD) • At close July 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 2.9612.9614.84.81.5651.565006.4176.417000.0590.0590.3060.3060.3870.387-0.243
Short Term Investments 55001010001010000000000.487
Cash and Short Term Investments 7.9617.9614.84.811.56511.5650016.41716.417000.0590.0590.3060.3060.3870.3870.243
Net Receivables 0.153000000000000000000
Inventory 0000-0.057000-0.028000-0.007000000
Other Current Assets 00.1535.0335.0330.1130.11314.19214.1920.0280.02819.01119.0110.0070.00700000
Total Current Assets 8.1148.1149.8339.83311.62111.62114.19214.19216.44516.44519.01119.0110.0670.0670.3060.3060.3870.3870.243
Non-Current Assets:
Property, Plant & Equipment, Net 0.2270.227000.8920.892001.461.46000.0820.0820.110.110.1080.1080
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 0000000000000000000
Long Term Investments 0000000000000000000
Tax Assets 0000000000000000000
Other Non-Current Assets 0.0980.0980.6420.6420.1080.1081.3561.3560.1140.1142.0522.0520.1910.1910.1840.1840.0190.019-0.243
Total Non-Current Assets 0.3240.3240.6420.642111.3561.3561.5741.5742.0522.0520.2730.2730.2940.2940.1270.127-0.243
Total Assets 8.4388.43810.47510.47512.62212.62215.54815.54818.01918.01921.06321.0630.340.340.60.60.5140.5140
Liabilities & Equity:
Current Liabilities:
Account Payables 0000000000000000000
Short Term Debt 0.060.06000.4380.438000.4110.4110.0011.3643.6823.6823.5433.5433.073.070
Tax Payables 0000000000000000000
Deferred Revenue 0000000000000000000
Other Current Liabilities 0.1340.134000.1690.169000.1670.167-0.00100.6560.6560.0420.0420.0950.0950
Total Current Liabilities 0.1940.194000.6070.607000.5780.5780.0011.3644.3384.3383.5853.5853.1653.1650
Non-Current Liabilities:
Long Term Debt 0.0260.026000.0250.025000.360.36000000000
Deferred Revenue Non-Current 0000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000
Other Non-Current Liabilities 0000.313000000000000000
Total Non-Current Liabilities 0.0260.0260.3130.3130.0250.0250.87400.360.36000000000
Total Liabilities 0.220.220.3130.3130.6320.6320.87400.9380.9381.3641.3644.3384.3383.5853.5853.1653.1650
Equity:
Preferred Stock 0000000000000000000
Common Stock 0010.16310.163000.01514.674000.0219.6990000000
Retained Earnings -21.617-21.61700-17.315-17.31500-11.444-11.44400-3.998-3.998-2.985-2.985-2.651-2.6510
Accumulated Other Comprehensive Income/Loss -0.046-0.04600-0.087-0.08700000000-0.0230-0.010-1.839
Other Total Stockholders Equity 29.88129.8810029.43229.43214.644028.50928.50900000.02300.0100
Total Shareholders Equity 8.2198.21910.16310.16312.0312.0314.65914.67417.06517.06519.69919.699-3.998-3.998-2.985-2.985-2.651-2.651-1.839
Total Equity 8.2198.21910.16310.16311.98911.98914.65914.67417.08117.08119.69919.699-3.998-3.998-2.985-2.985-2.651-2.651-1.839
Total Liabilities & Shareholders Equity 8.4388.43810.47510.47512.62212.62215.53314.67418.01918.01921.06321.0630.340.340.60.60.5140.514-1.839